Literature DB >> 29543114

Potential Public Health Effects of Reducing Nicotine Levels in Cigarettes in the United States.

Benjamin J Apelberg1, Shari P Feirman1, Esther Salazar1, Catherine G Corey1, Bridget K Ambrose1, Antonio Paredes1, Elise Richman1, Stephen J Verzi1, Eric D Vugrin1, Nancy S Brodsky1, Brian L Rostron1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29543114     DOI： 10.1056/NEJMsr1714617

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  56 in total

1.  The Public Health Gains Had Cigarette Companies Chosen to Sell Very Low Nicotine Cigarettes.

Authors:  David T Levy; K Michael Cummings; Bryan W Heckman; Yameng Li; Zhe Yuan; Tracy T Smith; Rafael Meza
Journal:  Nicotine Tob Res       Date:  2021-02-16       Impact factor: 4.244

2.  Overview of tobacco use transitions for population health.

Authors:  Andrew Hyland; Karin A Kasza; Nicolette Borek; Heather L Kimmel; Kristie A Taylor; Wilson M Compton; Hannah Day; Elisabeth A Donaldson; Eva Sharma; Gabriella Anic; Kathryn C Edwards; Michael J Halenar; Lynn C Hull; Wendy Kissin; Jean Limpert; Elizabeth L Seaman; Maansi Bansal-Travers; Lisa D Gardner; Hoda T Hammad; Cassandra A Stanton
Journal:  Tob Control       Date:  2020-05       Impact factor: 7.552

3.  Illicit Trade Poses No Threat to an FDA Rule to Minimize Nicotine in Smoked Tobacco Products.

Authors:  Eric N Lindblom
Journal:  Am J Public Health       Date:  2019-07       Impact factor: 9.308

4.  The past is not the future in tobacco control.

Authors:  K Michael Cummings; Scott Ballin; David Sweanor
Journal:  Prev Med       Date:  2020-06-27       Impact factor: 4.018

5.  Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial.

Authors:  Dorothy K Hatsukami; Xianghua Luo; Joni A Jensen; Mustafa al'Absi; Sharon S Allen; Steven G Carmella; Menglan Chen; Paul M Cinciripini; Rachel Denlinger-Apte; David J Drobes; Joseph S Koopmeiners; Tonya Lane; Chap T Le; Scott Leischow; Kai Luo; F Joseph McClernon; Sharon E Murphy; Viviana Paiano; Jason D Robinson; Herbert Severson; Christopher Sipe; Andrew A Strasser; Lori G Strayer; Mei Kuen Tang; Ryan Vandrey; Stephen S Hecht; Neal L Benowitz; Eric C Donny
Journal:  JAMA       Date:  2018-09-04       Impact factor: 56.272

Review 6.  Prevention and Treatment of Tobacco Use: JACC Health Promotion Series.

Authors:  Sara Kalkhoran; Neal L Benowitz; Nancy A Rigotti
Journal:  J Am Coll Cardiol       Date:  2018-08-28       Impact factor: 24.094

7.  Use of other combustible tobacco products among priority populations of smokers: Implications for U.S. tobacco regulatory policy.

Authors:  Claire Adams Spears; Dina M Jones; Terry F Pechacek; David L Ashley
Journal:  Addict Behav       Date:  2019-01-23       Impact factor: 3.913

8.  The Impact of Exclusive Use of Very Low Nicotine Cigarettes on Compensatory Smoking: An Inpatient Crossover Clinical Trial.

Authors:  Eric C Donny; Matthew J Carpenter; Tracy T Smith; Joseph S Koopmeiners; Cassidy M White; Rachel L Denlinger-Apte; Lauren R Pacek; Víctor R De Jesús; Lanqing Wang; Clifford Watson; Benjamin C Blount; Dorothy K Hatsukami; Neal L Benowitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02-26       Impact factor: 4.254

9.  Mouth-Level Nicotine Intake Estimates from Discarded Filter Butts to Examine Compensatory Smoking in Low Nicotine Cigarettes.

Authors:  Tracy T Smith; Joseph S Koopmeiners; Dorothy K Hatsukami; Katelyn M Tessier; Neal L Benowitz; Sharon E Murphy; Andrew A Strasser; Jennifer W Tidey; Benjamin C Blount; Liza Valentin; Roberto Bravo Cardenas; Clifford Watson; James L Pirkle; Eric C Donny
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02-26       Impact factor: 4.254

10.  Nondaily Smokers' Changes in Cigarette Consumption With Very Low-Nicotine-Content Cigarettes: A Randomized Double-blind Clinical Trial.

Authors:  Saul Shiffman; Brenda F Kurland; Sarah M Scholl; Jason M Mao
Journal:  JAMA Psychiatry       Date:  2018-10-01       Impact factor: 21.596
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.